Ownership Filing for BioStem Technologies, Inc.

This filing details the ownership of BioStem Technologies, Inc. (BSEM) by Jason Matuszewski, who holds multiple roles including CEO, Director, and a significant shareholder. The filing includes information on directly owned common stock, amounting to 1,278,433 shares. It also outlines various stock options and restricted stock units granted to Matuszewski, with details on their vesting schedules, exercise prices, and expiration dates. Notably, some options are fully vested, while others have staggered vesting over the next few years. The restricted stock units also have a three-year vesting period from their grant dates. The document is a Form 3, indicating initial or changed ownership.